LobbyingConvatec, Inc. F/K/A Triad Life Sciences lobbying by quarter
Convatec, Inc. F/K/A Triad Life Sciences's latest lobbying report covers Q2 2026, at $90K. The four quarters Q4 2025–Q3 2026 total $260K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.
Convatec, Inc. F/K/A Triad Life Sciences
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $260K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $50K | 1 |
| Q1 2023 | $50K | 1 |
| Q2 2023 | $50K | 1 |
| Q3 2023 | $50K | 1 |
| Q4 2023 | $50K | 1 |
| Q1 2024 | $50K | 1 |
| Q2 2024 | $70K | 1 |
| Q3 2024 | $70K | 1 |
| Q4 2024 | $70K | 1 |
| Q1 2025 | $70K | 1 |
| Q2 2025 | $80K | 1 |
| Q3 2025 | $80K | 1 |
| Q4 2025 | $80K | 1 |
| Q1 2026 | $90K | 1 |
| Q2 2026 | $90K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$1M · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Holland & Knight | $1M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| LARRY BUCSHON | Member, U.S. House of Representatives | Q2 2026 |
| JORDAN BROSSI | Staff Assist., Leg. Corr., Sen. Tammy Baldwin; Leg. Corr., Sen. Joe Manchin; LA, Rep. Susie Lee; Health LA, Health Policy Advisor, Rep. Anna Eshoo | Q1 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/13for Q2 | Holland & Knight | $90K |
| 04/17for Q1 | Holland & Knight | $90K |
| 01/11for Q4 2025 | Holland & Knight | $80K |
| 25/10/11for Q3 2025 | Holland & Knight | $80K |
| 25/07/06for Q2 2025 | Holland & Knight | $80K |
| 25/04/11for Q1 2025 | Holland & Knight | $70K |
| 25/01/11for Q4 2024 | Holland & Knight | $70K |
| 24/10/02for Q3 2024 | Holland & Knight | $70K |
| 24/07/06for Q2 2024 | Holland & Knight | $70K |
| 24/04/11for Q1 2024 | Holland & Knight | $50K |
| 24/01/06for Q4 2023 | Holland & Knight | $50K |
| 23/10/08for Q3 2023 | Holland & Knight | $50K |
| 23/07/09for Q2 2023 | Holland & Knight | $50K |
| 23/04/07for Q1 2023 | Holland & Knight | $50K |
| 23/01/09for Q4 2022 | Holland & Knight | $50K |